[Preprint] Incorporation of 5 methylcytidine alleviates innate immune response to self-amplifying RNA vaccine

VLP Therapeutics, Inc. (VLPT) researchers and their colleagues at the Boston University Chobanian & Avedisian School of Medicine posted on November 1 a preprint “Incorporation of 5 methylcytidine alleviates innate immune response to self-amplifying RNA vaccine” on bioRxiv, a preprint server for biology.

Note: Preprints are preliminary reports of work that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

• See the preprint abstract (full text also available): https://www.biorxiv.org/content/10.1101/2023.11.01.565056v1